Aromatase inhibition could be an alternative to testosterone administration to mitigate declining androgen production in hypogonadal older men. Unlike testosterone replacement, aromatase ...
1. 内分泌药物治疗时代 他莫昔芬(tamoxifen,TAM)、芳香化酶抑制剂(aromatase inhibitors,AI)、氟维司群(fulvestrant)是乳腺癌内分泌治疗的基本药物。 1977年,抗雌激素药物他莫昔芬在美国的获批拉开了内分泌治疗的序幕,标志着乳腺癌正式进入内分泌药物治疗 ...
MedPage Today on MSN20 小时
Year in Review: Early Breast Cancer
News in early breast cancer this year was marked by updated U.S. Preventive Services Task Force (USPSTF) screening ...
[13] Since this 2004 study, aromatase inhibitor use and any effect on cognition remain under consideration. A 2009 ASCO Breast Cancer Symposium review of five studies evaluated the majority of ...
Mabel Mardones, MD, Rocky Mountain Cancer Centers, discusses the future of HR+/HER2– breast cancer treatment, focusing on the importance of biomarkers and the potential of SIRDs to improve patient ...
I have been on an aromatase inhibitor for the past eight months and have side effects that keep me from having a good quality of life. I am supposed to be on it for five years, but I do not want ...
I have been on an aromatase inhibitor for the past eight months and have side effects that keep me from having a good quality of life. I am supposed to be on it for five years, but I do not want ...
Cognitive dysfunction has been considered as a morbid condition that may possibly result from aromatase inhibitor therapy, the standard treatment in postmenopausal, estrogen/progesterone receptor ...
DEAR DR. ROACH: I am an 80-year-old female and a 25-year survivor of ovarian cancer. In the past three years, I have also had Merkel cell cancer, breast cancer, and now squamous cell cancer on my lip.
In the past three years, I have also had Merkel cell cancer, breast cancer, and now squamous cell cancer on my lip. I have been on an aromatase inhibitor for the past eight months and have side ...
But she notes that researchers still don't know which strategy works best: taking an aromatase inhibitor instead of tamoxifen, as the first course of therapy after surgery for breast cancer ...